| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S40261-017-0539-7 |
| P698 | PubMed publication ID | 28597216 |
| P2093 | author name string | Hanne Haahr | |
| Leszek Nosek | |||
| Tim Heise | |||
| Ulrike Hövelmann | |||
| Bettina Sassenfeld | |||
| Karen Margrete Due Thomsen | |||
| P2860 | cites work | Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1). | Q48347749 |
| Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects. | Q51597891 | ||
| Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients. | Q51660823 | ||
| Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry | Q67508144 | ||
| The effect of subcutaneous injection site on absorption of human growth hormone: abdomen versus thigh | Q67887770 | ||
| Insulin absorption from the abdomen and the thigh in healthy subjects during rest and exercise: blood glucose, plasma insulin, growth hormone, adrenaline and noradrenaline levels | Q70230993 | ||
| Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen | Q70495296 | ||
| Absorption kinetics and biologic effects of subcutaneously injected insulin preparations | Q71490683 | ||
| Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin | Q71829414 | ||
| Pharmacodynamics of Insulin Preparations Administered in Different Subcutaneous Injection Sites: Are There Differences Between Healthy Subjects Versus Diabetic Patients? | Q88271055 | ||
| Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus | Q26471380 | ||
| Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions | Q33571532 | ||
| Glucose-lowering effect of insulin degludec is independent of subcutaneous injection region | Q34085107 | ||
| A review of the pharmacological properties of insulin degludec and their clinical relevance | Q34436383 | ||
| A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes | Q37742600 | ||
| Euglycaemic glucose clamp: what it can and cannot do, and how to do it. | Q38871135 | ||
| Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects | Q41689577 | ||
| A randomized, open-label, crossover study examining the effect of injection site on bioavailability of exenatide (synthetic exendin-4). | Q42652647 | ||
| The interpretation of glucose clamp studies of long-acting insulin analogues: from physiology to marketing and back. | Q46452341 | ||
| P433 | issue | 9 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| P1104 | number of pages | 3 | |
| P304 | page(s) | 885-887 | |
| P577 | publication date | 2017-09-01 | |
| P1433 | published in | Clinical Drug Investigation | Q15753215 |
| P1476 | title | Pharmacokinetic Properties of Fast-acting Insulin Aspart Administered in Different Subcutaneous Injection Regions: Response to the commentary by Nuggehally R. Srinivas | |
| P478 | volume | 37 |
Search more.